{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:48:30Z","timestamp":1783579710379,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Most studies investigated the relationship between COVID-19 and Guillain-Barr\u00e9 syndrome (GBS) by comparing the incidence of GBS before and during the pandemic of COVID-19. However, the findings were inconsistent, probably owing to varying degrees of the lockdown policy. The quarantine requirements and travel restrictions in China were lifted around December 7, 2022. This study aimed to explore whether the relative frequency of GBS increased during the major outbreak in the absence of COVID-19-mandated social restrictions in China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>GBS patients admitted to the First Hospital, Shanxi Medical University, from December 7, 2022 to February 20, 2023, and from June, 2017 to August, 2019 were included. The relative frequencies of GBS in hospitalized patients during different periods were compared. The patients with and without SARS-CoV-2 infection within six weeks prior to GBS onset formed the COVID-GBS group and non-COVID-GBS group, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The relative frequency of GBS among hospitalized patients during the major outbreak of COVID-19 (13\/14,408) was significantly higher than that before the COVID-19 epidemic (29\/160,669, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). More COVID-GBS patients (11\/13) presented AIDP subtype than non-COVID-GBS cases (10\/27, <jats:italic>P<\/jats:italic>\u2009=\u20090.003). The mean interval between onset of infective symptoms and GBS was longer in COVID-GBS (21.54\u2009\u00b1\u200911.56 days) than in non-COVID-GBS (5.76\u2009\u00b1\u20093.18 days, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>COVID-19 significantly increased the incidence of GBS. Most COVID-GBS patients fell into the category of AIDP, responded well to IVIg, and had a favorable prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09401-1","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:52:12Z","timestamp":1717062732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relative frequencies and clinical features of Guillain-Barr\u00e9 Syndrome before and during the COVID-19 pandemic in North China"],"prefix":"10.1186","volume":"24","author":[{"given":"Yaqian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"issue":"3","key":"9401_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141\u201354.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"9401_CR2","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s00415-021-10848-4","volume":"269","author":"E Beghi","year":"2022","unstructured":"Beghi E, Giussani G, Westenberg E, Allegri R, Garcia-Azorin D, Guekht A, Frontera J, Kivipelto M, Mangialasche F, Mukaetova-Ladinska EB, et al. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol. 2022;269(5):2265\u201374.","journal-title":"J Neurol"},{"issue":"10280","key":"9401_CR3","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barre syndrome. Lancet. 2021;397(10280):1214\u201328.","journal-title":"Lancet"},{"issue":"8","key":"9401_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469\u201382.","journal-title":"Nat Rev Neurol"},{"key":"9401_CR5","doi-asserted-by":"crossref","unstructured":"Nagappa M, Dutta D, Debnath M, Seshagiri D, Sreekumaran Nair B, Das S, Wahatule R, Sinha S, Ravi V, Taly A. Impact of antecedent infections on the antibodies against gangliosides and ganglioside complexes in Guillain-Barr\u00e9 syndrome: a correlative study. Ann Indian Acad Neurol 2022, 25(3).","DOI":"10.4103\/aian.aian_121_22"},{"issue":"3","key":"9401_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/jns.12459","volume":"26","author":"D Dutta","year":"2021","unstructured":"Dutta D, Debnath M, Nagappa M, Das SK, Wahatule R, Sinha S, Taly AB, Ravi V. Antecedent infections inGuillain-Barr\u00e9syndrome patients from south India. J Peripheral Nerv Syst. 2021;26(3):298\u2013306.","journal-title":"J Peripheral Nerv Syst"},{"issue":"4","key":"9401_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","volume":"268","author":"S Abu-Rumeileh","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133\u201370.","journal-title":"J Neurol"},{"key":"9401_CR8","doi-asserted-by":"crossref","unstructured":"Dutta D. NEUROLOGICAL IMPACT OF COVID-19 PANDEMIC: LESSONS & CAUTIONS. COVID-19 pandemic update 2020. Volume 8. Royal Book; Apr 2023. pp. 73\u201383.","DOI":"10.26524\/royal.37.5"},{"issue":"7","key":"9401_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/jnnp-2020-324837","volume":"92","author":"M Filosto","year":"2021","unstructured":"Filosto M, Cotti Piccinelli S, Gazzina S, Foresti C, Frigeni B, Servalli MC, Sessa M, Cosentino G, Marchioni E, Ravaglia S, et al. Guillain-Barre syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021;92(7):751\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"9401_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","volume":"144","author":"S Keddie","year":"2021","unstructured":"Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, Record CJ, Keh RYS, Fehmi J, Paterson RW, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome. Brain. 2021;144(2):682\u201393.","journal-title":"Brain"},{"key":"9401_CR11","doi-asserted-by":"crossref","unstructured":"Hafsteinsd\u00f3ttir B, Dalemo E, El\u00edasd\u00f3ttir \u00d3, \u00d3lafsson E, Axelsson MJN. Decreased incidence of Guillain-Barr\u00e9 syndrome during the COVID-19 pandemic: a Retrospective Population-based study. 2023, 57(1):1\u20136.","DOI":"10.1159\/000527726"},{"key":"9401_CR12","doi-asserted-by":"crossref","unstructured":"Fu D, He G, Li H, Tan H, Ji X, Lin Z, Hu J, Liu T, Xiao J, Liang X et al. Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and Symptoms \u2014 China, December 2022\u2013February 2023. In: China CDC Weekly vol. 5: Chinese Center for Disease Control and Prevention; 2023.","DOI":"10.46234\/ccdcw2023.070"},{"issue":"11","key":"9401_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain\u2013Barr\u00e9 syndrome in ten steps. Nat Reviews Neurol. 2019;15(11):671\u201383.","journal-title":"Nat Reviews Neurol"},{"issue":"5","key":"9401_CR14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s10072-019-03757-y","volume":"40","author":"A Giordano","year":"2019","unstructured":"Giordano A, Vabanesi M, Dalla Costa G, Cerri F, Comi G, Martinelli V, Fazio R. Assessing seasonal dynamics of Guillain-Barr\u00e9 syndrome with search engine query data. Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol. 2019;40(5):1015\u20138.","journal-title":"Neurol Sciences: Official J Italian Neurol Soc Italian Soc Clin Neurophysiol"},{"key":"9401_CR15","doi-asserted-by":"crossref","unstructured":"Turan Z, Topaloglu M, Ozyemisci Taskiran O. Medical Research Council-sumscore: a tool for evaluating muscle weakness in patients with post-intensive care syndrome. Crit Care 2020, 24(1).","DOI":"10.1186\/s13054-020-03282-x"},{"issue":"8093","key":"9401_CR16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2(8093):750\u20133.","journal-title":"Lancet"},{"issue":"5","key":"9401_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol. 1998;44(5):780\u20138.","journal-title":"Ann Neurol"},{"issue":"2","key":"9401_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0022-510X(93)90324-R","volume":"116","author":"TE Feasby","year":"1993","unstructured":"Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ. Severe axonal degeneration in acute Guillain-Barre syndrome: evidence of two different mechanisms? J Neurol Sci. 1993;116(2):185\u201392.","journal-title":"J Neurol Sci"},{"issue":"21","key":"9401_CR19","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","volume":"333","author":"JH Rees","year":"1995","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl J Med. 1995;333(21):1374\u20139.","journal-title":"N Engl J Med"},{"key":"9401_CR20","unstructured":"Diagnosis. and treatment protocol for novel coronavirus infection (Trial version 10). https:\/\/www.chinacdc.cn\/jkzt\/crb\/zl\/szkb_11803\/jszl_11815\/202301\/t20230107_263258.html. Accessed 1 January 2023."},{"key":"9401_CR21","unstructured":"COVID-19 Clinical and Surveillance Data \u2014 December 9. 2022 to March 23, 2023, China. https:\/\/weekly.chinacdc.cn\/news\/covid-surveillance\/28edabfb-94af-411c-a4d4-503e35d826fc_en.htm. Accessed 25 March 2023."},{"issue":"1","key":"9401_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2013","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 2013;137(1):33\u201343.","journal-title":"Brain"},{"key":"9401_CR23","volume-title":"Case Control studies","author":"SKC Tenny","year":"2023","unstructured":"Tenny SKC, Hoffman MR. Case Control studies. Treasure Island (FL): StatPearls; 2023."},{"issue":"3","key":"9401_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ana.25987","volume":"89","author":"M Fragiel","year":"2021","unstructured":"Fragiel M, Miro O, Llorens P, Jimenez S, Pinera P, Burillo G, Martin A, Martin-Sanchez FJ, Garcia-Lamberechts EJ, Jacob J, et al. Incidence, clinical, risk factors and outcomes of Guillain-Barre in Covid-19. Ann Neurol. 2021;89(3):598\u2013603.","journal-title":"Ann Neurol"},{"issue":"20","key":"9401_CR25","doi-asserted-by":"publisher","first-page":"e2035","DOI":"10.1212\/WNL.0000000000207900","volume":"101","author":"HAA Bishara","year":"2023","unstructured":"Bishara HAA, Barnett-Griness O, Bloch S, Cohen S, Najjar-Debbiny R, Gronich N, Auriel E, Saliba W. Association between Guillain-Barr\u00e9 syndrome and COVID-19 infection and vaccination: a Population-based nested case-control study. Neurology. 2023;101(20):e2035\u201342.","journal-title":"Neurology"},{"issue":"3","key":"9401_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/jnnp.2010.226639","volume":"82","author":"J Drenthen","year":"2011","unstructured":"Drenthen J, Yuki N, Meulstee J, Maathuis EM, van Doorn PA, Visser GH, Blok JH, Jacobs BC. Guillain-Barr\u00e9 syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatry. 2011;82(3):300\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"9401_CR27","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1212\/NXI.0000000000000575","volume":"6","author":"M Yamana","year":"2019","unstructured":"Yamana M, Kuwahara M, Fukumoto Y, Yoshikawa K, Takada K, Kusunoki S. Guillain-Barr\u00e9 syndrome and related diseases after influenza virus infection. Neurology(R) Neuroimmunol Neuroinflammation. 2019;6(4):e575.","journal-title":"Neurology(R) Neuroimmunol Neuroinflammation"},{"issue":"12","key":"9401_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1474-4422(13)70215-1","volume":"12","author":"S Kuwabara","year":"2013","unstructured":"Kuwabara S, Yuki N. Axonal Guillain-Barr\u00e9 syndrome: concepts and controversies. Lancet Neurol. 2013;12(12):1180\u20138.","journal-title":"Lancet Neurol"},{"issue":"6","key":"9401_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mus.27414","volume":"64","author":"F Zhao","year":"2021","unstructured":"Zhao F, Wang J, Zhang J, Pang X, Huang S, Chang X, Guo J, Zhang W. Pain in acute motor axonal neuropathy. Muscle Nerve. 2021;64(6):739\u201343.","journal-title":"Muscle Nerve"},{"issue":"4","key":"9401_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","volume":"62","author":"JB Caress","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, Narayanaswami P. COVID-19-associated Guillain-Barre syndrome: the early pandemic experience. Muscle Nerve. 2020;62(4):485\u201391.","journal-title":"Muscle Nerve"},{"issue":"23","key":"9401_CR31","doi-asserted-by":"publisher","first-page":"e2386","DOI":"10.1212\/WNL.0000000000207282","volume":"100","author":"H Al-Hakem","year":"2023","unstructured":"Al-Hakem H, Doets AY, Stino AM, Zivkovic SA, Andersen H, Willison HJ, Cornblath DR, Gorson KC, Islam Z, Mohammad QD, et al. CSF findings in relation to clinical characteristics, subtype, and Disease Course in patients with Guillain-Barr\u00e9 Syndrome. Neurology. 2023;100(23):e2386\u201397.","journal-title":"Neurology"},{"key":"9401_CR32","doi-asserted-by":"publisher","first-page":"755579","DOI":"10.3389\/fimmu.2021.755579","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Liao X, Song X, He M, Xiao F, Jin X, Xie X, Zhang Z, Wang B, Zhou C, et al. Severe adaptive Immune suppression may be why patients with severe COVID-19 cannot be discharged from the ICU even after negative viral tests. Front Immunol. 2021;12:755579.","journal-title":"Front Immunol"},{"issue":"1","key":"9401_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12879-022-07192-x","volume":"22","author":"A De Bruyn","year":"2022","unstructured":"De Bruyn A, Verellen S, Bruckers L, Geebelen L, Callebaut I, De Pauw I, Stessel B, Dubois J. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation. BMC Infect Dis. 2022;22(1):207.","journal-title":"BMC Infect Dis"},{"key":"9401_CR34","doi-asserted-by":"crossref","unstructured":"Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, Zhu F, Zhu B, Cui L. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res 2020, 285.","DOI":"10.1016\/j.virusres.2020.198005"},{"key":"9401_CR35","doi-asserted-by":"publisher","first-page":"100578","DOI":"10.1016\/j.bbih.2022.100578","volume":"28","author":"V Pimentel","year":"2023","unstructured":"Pimentel V, Luchsinger VW, Carvalho GL, Alcara AM, Esper NB, Marinowic D, Zanirati G, da Costa JC. Guillain-Barre syndrome associated with COVID-19: a systematic review. Brain Behav Immun Health. 2023;28:100578.","journal-title":"Brain Behav Immun Health"},{"issue":"10027","key":"9401_CR36","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French polynesia: a case-control study. Lancet. 2016;387(10027):1531\u20139.","journal-title":"Lancet"},{"key":"9401_CR37","doi-asserted-by":"crossref","unstructured":"Ramos AP, Leonhard SE, Halstead SK, Cuba MA, Castaneda CC, Dioses JA, Tipismana MA, Abanto JT, Llanos A, Gourlay D et al. Guillain-Barre Syndrome Outbreak in Peru 2019 Associated with Campylobacter jejuni infection. Neurol Neuroimmunol Neuroinflamm 2021, 8(2).","DOI":"10.1212\/NXI.0000000000000952"},{"issue":"12","key":"9401_CR38","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1056\/NEJMc1916977","volume":"383","author":"G Wang","year":"2020","unstructured":"Wang G, Li H, Yang X, Guo T, Wang L, Zhao Z, Sun H, Hou X, Ding X, Dou C, et al. Guillain-Barre Syndrome Associated with JEV infection. N Engl J Med. 2020;383(12):1188\u201390.","journal-title":"N Engl J Med"},{"issue":"2","key":"9401_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/ene.12565","volume":"22","author":"JO Sipila","year":"2015","unstructured":"Sipila JO, Soilu-Hanninen M. The incidence and triggers of adult-onset Guillain-Barre syndrome in southwestern Finland 2004\u20132013. Eur J Neurol. 2015;22(2):292\u20138.","journal-title":"Eur J Neurol"},{"issue":"5","key":"9401_CR40","doi-asserted-by":"publisher","first-page":"e875","DOI":"10.1002\/iid3.875","volume":"11","author":"M Malekpour","year":"2023","unstructured":"Malekpour M, Khanmohammadi S, Meybodi MJE, Shekouh D, Rahmanian MR, Kardeh S, Azarpira N. COVID-19 as a trigger of Guillain-Barre syndrome: a review of the molecular mechanism. Immun Inflamm Dis. 2023;11(5):e875.","journal-title":"Immun Inflamm Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09401-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09401-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:52:20Z","timestamp":1717062740000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09401-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9401"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09401-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Institutional Ethics Committee of the First Hospital of Shanxi Medical University and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments (NO. KYLL-2023-133). Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"541"}}